Idaho continues to have one of the highest rates of COVID-19 per capita. As pharmaceutical companies race to find a vaccine, therapeutic treatments to help those already infected are vital.
One experimental treatment? Using plasma from the blood of people who have already recovered from the coronavirus.
The Red Cross is one of the organizations working on this possible lifesaving treatment. But to know whether it is effective, they need plasma donors.
Nicole Irwin is the CEO of the Red Cross in Idaho and Montana, and Dr. Walter Kelley is the organization’s medical director for the region. Both join Idaho Matters live to talk more about this possible treatment.
As COVID-19 cases spread through the U.S. and Idaho, we’re committed to keeping you updated and informed. You can get updated info on cases, closures and how to stay healthy at any time on our Coronavirus news blog.
Have a question or comment for the show? Tweet @KBSX915 using #IdahoMatters
Member support is what makes local COVID-19 reporting possible. Support this coverage here.